Metformin effect on Soft Tissue Rheumatism patients with Insulin Resistance

Phase 4

Recruiting

• Conditions: Soft Tissue Rheumatism.Insulin Resistance; Soft tissue rheumatism.; Insulin resistance..; Metformin.

• Registration Number: TCTR20230614001
• Lead Sponsor: Alazhar University Hospital at New Damietta

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-14
• Study Completion: 2024-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1.Patient diagnosed as having soft tissue rheumatism (Plantar fasciitis,
rotator cuff tendinitis), 2.Age ranges from eighteen (18) to sixty (60) years to avoid complaints related to congenital causes as uneven legs, Multidirectional shoulder instability or aging, 3.Body mass index > 25

Exclusion Criteria

1.History of trauma, 2.Overwork, Unaccustomed activities, 3.Systemic rheumatic diseases, severe co-morbid diseases, Diabetes mellitus, 4.Drugs that can affect insulin resistance or musculoskeletal system, 5.Poor postures and poor footwear.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement soft tissue rheumatism At 12 months after end of the intervention VAS score

Secondary Outcome Measures

Name	Time	Method
Improvement of Homa-IR At 12 months after end of the intervention Homa-IR